Andrew Witriol
Vice President, U.S. Oncology Marketing
Bio:
Andrew's work focuses on driving enterprise success, leading strategic initiatives, and accelerating the growth of the Oncology portfolio at BMS to transform outcomes for people living with cancer. In Andrew's 20+ years at BMS, he has contributed firsthand to the company’s Oncology organization - from pioneering Immuno-Oncology to advancing novel therapies for multiple myeloma and lymphoma through its pipeline, to leading delivery plans for approved treatments to patients with conditions such as Myelodysplastic Syndromes (MDS)-related anemia. In addition to Andrew's role at BMS, he serves on the Board of Directors for Good Grief Inc., a charitable organization whose goal is to build resilience in children, strengthen families and empower communities to grow from loss and adversity.